WO2010068056A3 - Composition containing glucosamine or glucosamine derivative for preventing or treating hemadostenosis and restenosis - Google Patents

Composition containing glucosamine or glucosamine derivative for preventing or treating hemadostenosis and restenosis Download PDF

Info

Publication number
WO2010068056A3
WO2010068056A3 PCT/KR2009/007415 KR2009007415W WO2010068056A3 WO 2010068056 A3 WO2010068056 A3 WO 2010068056A3 KR 2009007415 W KR2009007415 W KR 2009007415W WO 2010068056 A3 WO2010068056 A3 WO 2010068056A3
Authority
WO
WIPO (PCT)
Prior art keywords
glucosamine
hemadostenosis
restenosis
treating
preventing
Prior art date
Application number
PCT/KR2009/007415
Other languages
French (fr)
Korean (ko)
Other versions
WO2010068056A2 (en
Inventor
김수열
김대중
Original Assignee
국립암센터
강원대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 국립암센터, 강원대학교산학협력단 filed Critical 국립암센터
Publication of WO2010068056A2 publication Critical patent/WO2010068056A2/en
Publication of WO2010068056A3 publication Critical patent/WO2010068056A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Abstract

The present invention relates to a novel use of glucosamine or its derivative. More specifically, the present invention relates to a composition containing glucosamine, glucosamine derivative, or the salt thereof for preventing or treating hemadostenosis and restenosis and a method for preventing or treating hemadostenosis and restenosis using the composition.
PCT/KR2009/007415 2008-12-11 2009-12-11 Composition containing glucosamine or glucosamine derivative for preventing or treating hemadostenosis and restenosis WO2010068056A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2008-0125616 2008-12-11
KR1020080125616A KR20100067170A (en) 2008-12-11 2008-12-11 A composition for treating or preventing angiostenosis and restenosis comprising glucosamine and derivatives thereof

Publications (2)

Publication Number Publication Date
WO2010068056A2 WO2010068056A2 (en) 2010-06-17
WO2010068056A3 true WO2010068056A3 (en) 2010-10-21

Family

ID=42243234

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/007415 WO2010068056A2 (en) 2008-12-11 2009-12-11 Composition containing glucosamine or glucosamine derivative for preventing or treating hemadostenosis and restenosis

Country Status (2)

Country Link
KR (1) KR20100067170A (en)
WO (1) WO2010068056A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834444A (en) * 1991-07-03 1998-11-10 Hyal Pharmaceutical Corporation Hyaluronic acid and salts thereof inhibit arterial restenosis
US20020077314A1 (en) * 1991-07-03 2002-06-20 Rudolf E. Falk Use of hyaluronic acid and forms to prevent arterial restenosis
US6596708B1 (en) * 2001-09-07 2003-07-22 Advanced Medical Instruments Composition for the treatment and prevention of endothelial dysfunction
US20050239743A1 (en) * 2004-04-12 2005-10-27 Pro-Pharmaceuticals, Inc. Compositions and methods to inhibit restenosis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834444A (en) * 1991-07-03 1998-11-10 Hyal Pharmaceutical Corporation Hyaluronic acid and salts thereof inhibit arterial restenosis
US20020077314A1 (en) * 1991-07-03 2002-06-20 Rudolf E. Falk Use of hyaluronic acid and forms to prevent arterial restenosis
US6596708B1 (en) * 2001-09-07 2003-07-22 Advanced Medical Instruments Composition for the treatment and prevention of endothelial dysfunction
US20050239743A1 (en) * 2004-04-12 2005-10-27 Pro-Pharmaceuticals, Inc. Compositions and methods to inhibit restenosis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
STRINGER, S. E. ET AL.: "Heparan Sulphate.", INT. J. BIOCHEM. CELL BIOL., vol. 29, no. 5, 1997, pages 709 - 714 *

Also Published As

Publication number Publication date
WO2010068056A2 (en) 2010-06-17
KR20100067170A (en) 2010-06-21

Similar Documents

Publication Publication Date Title
EP2331093A4 (en) Compounds, compositions and methods for reducing toxicity and treating or preventing diseases
WO2007093627A3 (en) Biocidal composition
AP2012006191A0 (en) Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same.
WO2009117421A3 (en) Heterocyclic modulators of gpr119 for treatment of disease
WO2009156462A3 (en) Organic compounds
WO2006113919A3 (en) Aryl alkyl acid derivatives for and use thereof
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2009065738A3 (en) Polyoxyalkylenamines for improved fragrance yield
WO2008152131A3 (en) Rnai inhibition of alpha-enac expression
WO2009117676A3 (en) Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase
WO2010062377A3 (en) Methods and compositions for the detection and treatment of preeclampsia
WO2010072787A3 (en) A composition comprising a retinoid and method of treating skin conditions
ZA200908612B (en) 1,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylase
WO2012017321A3 (en) Treatment for dyslipidemia
WO2010005565A3 (en) Method of treating glycogen storage disease
WO2009092052A3 (en) Methods and compositions for treating polyps
WO2009129497A3 (en) Methods and compositions for treating age-related macular degeneration
WO2010098583A3 (en) Novel method for preparing statin compounds or salts thereof, and intermediate compounds used in same
WO2007137098A3 (en) Sulfonyl-substituted bicyclic compounds as modulators of ppar
WO2010148177A3 (en) Compounds, compositions, methods of synthesis, and methods of treatment
WO2010042212A3 (en) Methods for treating or preventing pain using spicamycin derivatives
WO2011028890A3 (en) Compositions and methods for treatment of neuropathic pain
WO2009126335A3 (en) Ant2 inhibitor compounds and methods of use thereof
WO2008089005A3 (en) Renin inhibitors
MX2011010046A (en) Diaminopteridine derivatives.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09832141

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09832141

Country of ref document: EP

Kind code of ref document: A2